Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-03-25 | Roger D. Dansey, M.D. Age: 66 Director Since: 2021 Director The members of the Nomination and Corporate Governance Committee currently are Simon X. Benito (Chair), Roger D. Dansey, Jay P. Shepard and Wendy L. Yarno. Director Compensation Table Roger D. Dansey, M.D. Fees Earned or Paid in Cash ($): 43,750 Stock Awards ($): 224,280 Option Awards ($): 249,610 Total ($): 517,640 |
| 2023-03-28 | Roger D. Dansey, M.D. Age: 67 Director Since: 2021 Director The members of the Nomination and Corporate Governance Committee currently are Simon X. Benito (Chair), Roger D. Dansey, Jay P. Shepard and Wendy L. Yarno. Director Compensation Table Roger D. Dansey, M.D. Fees Earned or Paid in Cash ($): 67,500 Stock Awards ($): 35,910 Option Awards ($): 40,434 Total ($): 143,844 |
| 2023-11-28 | Directors and Named Executive Officers: Roger D. Dansey, M.D. |
| 2024-04-11 | Roger D. Dansey, M.D. Age: 68 Director Since: 2021 Dr. Dansey currently serves as the Chief Development Officer for Pfizer Oncology following Pfizer's acquisition of Seagen. The members of the Nomination and Corporate Governance Committee currently are Simon X. Benito (Chair), Roger D. Dansey, Jay P. Shepard and Wendy L. Yarno. Director Compensation Table Roger D. Dansey, M.D. Fees Earned or Paid in Cash ($): 67,500 Stock Awards ($): 20,014 Option Awards ($): 21,171 Total ($): 108,685 |
| 2025-04-07 | Roger D. Dansey, M.D., Age: 69, Director. Committee: Nomination and Corporate Governance Committee (Member). Total compensation: $117,341. |
Data sourced from SEC filings. Last updated: 2026-03-05